The Supreme Court is considering whether to block or limit billions of dollars in pending Roundup cancer litigation against Monsanto (now Bayer). The case raises questions about corporate accountability for product safety and the scope of class-action lawsuits against agrochemical manufacturers. The Court's decision will determine whether individuals who developed cancer allegedly from Roundup exposure can pursue damage claims against the manufacturer.
The specific procedural question is whether the Court will reduce, eliminate, or sustain the pending liability. Bayer (which acquired Monsanto) faces billions in potential damages from thousands of individual cancer claims tied to Roundup (glyphosate) exposure. Bayer has incentive to seek Supreme Court review to either overturn adverse judgments or limit class certification. The Court's willingness to hear the case suggests at least some justices believe the liability is problematic.
The doctrinal significance is that the case tests the scope of corporate liability for products that may cause harm. Monsanto maintained that Roundup was safe; users claimed otherwise and sued. Juries in some cases awarded damages; courts permitted class certification in others. The Supreme Court's intervention suggests it believes the litigation scope is inappropriate, either because the evidence is insufficient or because class-action procedures are inappropriate for this type of claim.
The public health dimension is significant because Roundup is the most-used herbicide globally. Millions of farmers, gardeners, and landscapers have been exposed to it. If the Supreme Court limits liability, it signals that manufacturers cannot be held accountable for harms from widely-used products even if individuals claim injury. If the Court sustains liability, it signals that manufacturers bear responsibility for product safety and must compensate injured users.
Historically, product liability litigation has driven significant safety improvements. The tobacco litigation, asbestos litigation, and other major product cases forced companies to acknowledge harms and change practices. Limitations on product liability typically reduce safety incentives because companies face less financial consequence for harmful products.
Watch for: (1) the Supreme Court's decision and whether it sustains or limits liability, (2) the specific reasoning the Court provides, (3) whether Bayer settles pending cases rather than pursue appeal, (4) the amount of settlements if they occur, (5) whether the decision affects other pending product liability litigation, (6) whether agricultural safety regulations change in response, and (7) whether international courts impose different liability standards than US courts.